<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
0002-7722-11
</NDCCode>
<PackageDescription>
1 KIT in 1 CARTON (0002-7722-11) * 1 mL in 1 SYRINGE (0002-8870-01) * 2 mL in 1 SYRINGE (0002-1442-01)
</PackageDescription>
<NDC11Code>
00002-7722-11
</NDC11Code>
<ProductNDC>
0002-7722
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Omvoh
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Mirikizumab-mrkz
</NonProprietaryName>
<DosageFormName>
KIT
</DosageFormName>
<RouteName>
SUBCUTANEOUS; SUBCUTANEOUS
</RouteName>
<StartMarketingDate>
20250115
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
BLA
</MarketingCategoryName>
<ApplicationNumber>
BLA761279
</ApplicationNumber>
<LabelerName>
Eli Lilly and Company
</LabelerName>
<SubstanceName/>
<StrengthNumber/>
<StrengthUnit/>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-12-19
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20250115
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>